Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 1936 AL 1950

Unlocking the Potential of Oxymatrine: A Comprehensive Review of Its Neuroprotective Mechanisms and Therapeutic Prospects in Neurological Disorders

Dhurandhar Y, Tomar S, Das A, Singh AP, Prajapati JL, Bodakhe SH, Namdeo KP.

ACS Chem Neurosci. 2024 Dec 4;15(23):4245-4257. doi: 10.1021/acschemneuro.4c00338. Epub 2024 Nov 14.

NOX2 in Alzheimer's and Parkinson's disease

Dustin CM, Shiva SS, Vazquez A, Saeed A, Pascoal T, Cifuentes-Pagano E, Pagano PJ.

Redox Biol. 2024 Dec;78:103433. doi: 10.1016/j.redox.2024.103433. Epub 2024 Nov 15.

Primary familial brain calcification presenting with parkinsonism and motor complications caused by a novel SLC20A2 variant: a case report

Sun D, Wang Y, Wang J, Wang S, Zhu L, Xia K, Zhang Y, Wang X.

Front Neurol. 2024 Jul 5;15:1382534. doi: 10.3389/fneur.2024.1382534. eCollection 2024.

Neuroprotective properties of Betulin, Betulinic acid, and Ursolic acid as triterpenoids derivatives: a comprehensive review of mechanistic studies

Farzan M, Farzan M, Shahrani M, Navabi SP, Vardanjani HR, Amini-Khoei H, Shabani S.

Nutr Neurosci. 2024 Mar;27(3):223-240. doi: 10.1080/1028415X.2023.2180865. Epub 2023 Feb 23.

Natural Products as Monoamine Oxidase Inhibitors: Potential Agents for Neurological Disorders

Agrawal N, Bhardwaj A, Singh S, Goyal A, Gaurav A.

Comb Chem High Throughput Screen. 2024;27(5):701-714. doi: 10.2174/1386207326666230510141008.

Underlying Mechanisms and Treatment of Cellular Senescence-Induced Biological Barrier Interruption and Related Diseases

Sun R, Feng J, Wang J.

Aging Dis. 2024 Apr 1;15(2):612-639. doi: 10.14336/AD.2023.0621.

Polyoxidovanadates a new therapeutic alternative for neurodegenerative and aging diseases

Gonzalez-Cano SI, Flores G, Guevara J, Morales-Medina JC, Treviño S, Diaz A.

Neural Regen Res. 2024 Mar;19(3):571-577. doi: 10.4103/1673-5374.380877.

Pharmacological update of mirtazapine: a narrative literature review

Hassanein EHM, Althagafy HS, Baraka MA, Abd-Alhameed EK, Ibrahim IM.

Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2603-2619. doi: 10.1007/s00210-023-02818-6. Epub 2023 Nov 9.

Phototherapy for age-related brain diseases: Challenges, successes and future

Ding L, Gu Z, Chen H, Wang P, Song Y, Zhang X, Li M, Chen J, Han H, Cheng J, Tong Z.

Ageing Res Rev. 2024 Feb;94:102183. doi: 10.1016/j.arr.2024.102183. Epub 2024 Jan 11.

Phenolic Compounds of Therapeutic Interest in Neuroprotection

Nájera-Maldonado JM, Salazar R, Alvarez-Fitz P, Acevedo-Quiroz M, Flores-Alfaro E, Hernández-Sotelo D, Espinoza-Rojo M, Ramírez M.

J Xenobiot. 2024 Feb 6;14(1):227-246. doi: 10.3390/jox14010014.

Real-world value of cabergoline in the treatment of acromegaly

Shimon I.

Best Pract Res Clin Endocrinol Metab. 2024 Jul;38(4):101887. doi: 10.1016/j.beem.2024.101887. Epub 2024 Feb 28.

PET brain imaging in neurological disorders

Xie L, Zhao J, Li Y, Bai J.

Phys Life Rev. 2024 Jul;49:100-111. doi: 10.1016/j.plrev.2024.03.007. Epub 2024 Mar 24.

Therapeutic role of PTEN in tissue regeneration for management of neurological disorders: stem cell behaviors to an in-depth review

Li Y, Ma R, Hao X.

Cell Death Dis. 2024 Apr 16;15(4):268. doi: 10.1038/s41419-024-06657-y.

Mind over Microplastics: Exploring Microplastic-Induced Gut Disruption and Gut-Brain-Axis Consequences

Sofield CE, Anderton RS, Gorecki AM.

Curr Issues Mol Biol. 2024 Apr 30;46(5):4186-4202. doi: 10.3390/cimb46050256.

Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction

Lee B, Lee SM, Song JW, Choi JW.

Biomol Ther (Seoul). 2024 Jul 1;32(4):403-423. doi: 10.4062/biomolther.2024.009. Epub 2024 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias